Alerts will be sent to your verified email
Verify EmailFORTIS
Fortis Healthcare
|
Sanofi India
|
Ajanta Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Diagnostics
|
|||
Realization/Patient - Diagnostic Centres
|
829.0 Rs/Patient | n/a | n/a |
Number of Daily Patients - Diagnostic Centres
|
45.89 Ths | n/a | n/a |
Operating Margin/Test - Diagnostic Centres
|
66.82 Rs/Test | n/a | n/a |
Realization/Test - Diagnostic Centres
|
344.0 Rs/Test | n/a | n/a |
Cost/Test - Diagnostic Centres
|
128.0 Rs/Test | n/a | n/a |
No of Tests - Quarterly
|
9.95 Mn | n/a | n/a |
Hospital Sector
|
|||
Average Daily Revenue Per Occupied Bed
|
61096.0 Rs | n/a | n/a |
Hospital Occupancy Rate
|
64.0 % | n/a | n/a |
Average Length Of Stay
|
4.32 Days | n/a | n/a |
Operational Beds
|
4500.0 . | n/a | n/a |
Unclassified
|
|||
Number of Outpatient Visits - Quarterly
|
708300.0 . | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
2.33 % | 43.25 % | 19.25 % |
5yr average Equity Multiplier
|
1.73 | 3.33 | 1.34 |
5yr Average Asset Turnover Ratio
|
0.44 | 0.57 | 0.75 |
5yr Avg Net Profit Margin
|
2.18 % | 22.99 % | 19.31 % |
Price to Book
|
4.4 | 18.78 | 7.96 |
P/E
|
60.61 | 31.62 | 37.67 |
5yr Avg Cash Conversion Cycle
|
-133.71 Days | 11.11 Days | 19.66 Days |
Inventory Days
|
6.17 Days | 48.47 Days | 74.91 Days |
Days Receivable
|
31.7 Days | 13.83 Days | 99.85 Days |
Days Payable
|
220.67 Days | 55.71 Days | 219.9 Days |
5yr Average Interest Coverage Ratio
|
3.83 | 1007.93 | 165.94 |
5yr Avg ROCE
|
4.56 % | 29.56 % | 24.04 % |
5yr Avg Operating Profit Margin
|
14.05 % | 28.62 % | 29.77 % |
5 yr average Debt to Equity
|
0.19 | 0.0 | 0.01 |
5yr CAGR Net Profit
|
n/a | 41.96 % | 8.73 % |
5yr Average Return on Assets
|
1.32 % | 13.01 % | 14.36 % |
Shareholdings
|
|||
Promoter Holding
|
31.17 % | 60.4 % | 66.21 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 12.26 % |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -4.13 % |
Change in Mutual Fund Holding (3 Yrs)
|
14.26 % | 1.86 % | 5.23 % |
Fortis Healthcare
|
Sanofi India
|
Ajanta Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Segment Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Customer Segment
|
Customer Segment
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|